Baldridge receives NIH grant to study regulation of hematopoiesis

Megan Baldridge, MD, PhD, assistant professor of medicine at the School of Medicine, received a $2.4 million five-year grant from the National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases, in collaboration with Katherine King, MD, PhD, of Baylor College of Medicine. Their research is titled “Microbiota-dependent regulation of primitive hematopoiesis.”

Five inducted into Bouchet Graduate Honor Society

Five PhD candidates at Washington University in St. Louis were inducted into the Edward A. Bouchet Graduate Honor Society at the annual Bouchet Conference on Diversity and Graduate Education April 5-6 at Yale University.

Combining law and medicine

Testifying on U.S. gun violence in Bogota, Colombia. Presenting on privacy in the digital age. Writing a dissertation on clinical whole-genome sequencing data. Making the Dean’s List. All in a day’s work for Jiyeon Kim, who will be graduating with a doctor of law from the School of Law and who plans a career focused on health and technology law and policy.

Class Acts: Committed to cultural understanding

Entering college, Haley Allen knew she wanted to join ROTC so she could be an officer in the U.S. Army. But an ROTC trip Tanzania sparked a passion for Swahili and East African culture and history. She graduates this month with a degree in international studies and hopes to serve in Africa after completing helicopter training at Fort Rucker, Alabama.

Colonna, Ley elected to National Academy of Sciences

Marco Colonna, MD, the Robert Rock Belliveau, MD, Professor of Pathology (left), and Timothy J. Ley, MD, the Lewis T. and Rosalind B. Apple Chair in Oncology, both at the School of Medicine, have been elected to the National Academy of Sciences. The new members were announced April 30.

Prescription drug affordability

Rachel Sachs
A final judgment invalidating the entire Affordable Care Act as unconstitutional would not only harm those in the individual market or Medicaid expansion—but would also jeopardize the ability of even more Americans to afford their prescription drugs.